Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
A Kerry student has won the top prize at this year's Stripe Young Scientist and Technology Exhibition for her brain cancer ...
SOPHiA GENETICS and MD Anderson announce strategic collaboration to accelerate AI driven precision oncology: Boston, Massachusetts Friday, January 9, 2026, 17:00 Hrs [IST] SOPHiA ...
Dr Raman Narang, a Delhi-based oncologist, is at the forefront of the shift toward personalized cancer treatment. He focuses ...
When most people think about cancer, they think of bad luck, lifestyle choices, or something that “just happens.” Very few ...
DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.
IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young adults under the age of 50.
ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...
Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...
About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback